• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

F.D.A. Approves New Nasal Spray for Migraines

The New York Times – Business:

Pfizer’s treatment applies an approach that is different from some other products, which doctors say may make it safer for people at risk of heart attacks or stroke.

Christina Jewett
Author: Christina Jewett

This post first appeared in The New York Times – Business. Read the original article.

Written by

Christina Jewett

in

Drugs (Pharmaceuticals), Food and Drug Administration, Lancet Neurology, The (Journal), Migraine Headaches, Nerves and Nervous System, Pfizer Inc
←RuPaul Shreds ‘Stunt Queen’ Politicians Pushing To Ban Drag Shows In Fiery Video
Michael Tilson Thomas Revels in the Present With the New York Phil→

More posts

  • Spotify once had a reputation for underpaying music artists. It hopes to change that perception

  • How Trump and His Advisers Miscalculated Iran’s Response to War

  • Mickey Rourke evicted over $60,000 in unpaid rent after turning down $100,000 in donations

  • Georgia special election to replace Marjorie Taylor Greene headed to runoff

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube